MUHC in the Media - October 27, 2025

The new Day Medicine Unit is steadily taking shape and will soon provide patients and staff with larger, more modern spaces designed for outpatient care. In a recent article published on our platforms, Marie-Ève Dagneault, Nurse Manager at the heart of this transformation, explained the improvements associated with this change. Her insights also caught the attention of The Suburban newspaper.

A clinical trial conducted by Dr. Étienne de Villers-Sidani, a neurologist specializing in cognitive disorders at The Neuro, has demonstrated for the first time in humans that intensive mental training can rejuvenate the brain circuits linked to memory and attention, abilities that are often affected by age. While previous research had already shown that this type of training could improve or slow the decline in cognitive performance, this study now reveals the concrete changes observed in the brain after such a program. Le Devoir 

Montreal researchers, including Dr. Kevin Petrecca of The Neuro , have developed a new tool to combat glioblastoma, a brain cancer so ruthless that some have dubbed it the “Terminator.” La Presse, Noovo, City News

Lecanemab is a “monoclonal antibody” that targets amyloid plaques, deposits in the brain that are associated with Alzheimer's disease. Interview with Dr. Simon Ducharme, neuropsychiatrist at the MUHC, and other experts.
La Presse

After analyzing the economic and health issues, the Quebec Immunization Committee recommended that only certain vulnerable groups receive the vaccine free of charge, explains Dr. Jesse Papenburg, pediatric infectious disease specialist and medical microbiologist at the Montreal Children's Hospital. Radio-Canada